| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-5728(96)00178-6 |
| P698 | PubMed publication ID | 9042104 |
| P2093 | author name string | Majzoub JA | |
| Karalis K | |||
| Hilderbrand H | |||
| Bae D | |||
| Muglia LJ | |||
| P2860 | cites work | Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 |
| A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats | Q33864605 | ||
| Glucocorticosteroid therapy: mechanisms of action and clinical considerations | Q34058573 | ||
| Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells | Q34144521 | ||
| Neuroendocrine-immune system interactions and autoimmunity | Q34300053 | ||
| The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis | Q34350872 | ||
| T-cell tolerance | Q35604977 | ||
| Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis | Q35614089 | ||
| Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis | Q35872927 | ||
| Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration | Q35912859 | ||
| Corticotropin-releasing factor mRNA in rat thymus and spleen | Q36450969 | ||
| The immune-hypothalamic-pituitary-adrenal axis | Q38667681 | ||
| Stimulation of the hypothalamo-pituitary-adrenal axis by compounds formed in inflamed tissue | Q39997350 | ||
| Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions* | Q40172536 | ||
| The endocrine response to critical illness. | Q40561254 | ||
| The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses | Q40619075 | ||
| Corticotrophin-releasing factor as a mediator of the acute-phase response in rats, mice and rabbits | Q40722219 | ||
| Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals | Q40756023 | ||
| Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates | Q40779546 | ||
| Corticotropin-releasing factor and interleukin-1 receptors in the brain-endocrine-immune axis. Role in stress response and infection | Q40788456 | ||
| Interleukin-1 beta enhances corticosterone secretion by acting directly on the rat adrenal gland. | Q41129657 | ||
| In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. | Q41273561 | ||
| Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist | Q41335474 | ||
| Thymocyte apoptosis induced by elevated endogenous corticosterone levels | Q41469358 | ||
| Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. | Q41710815 | ||
| A stimulatory effect of interleukin-1 on adrenocortical cortisol secretion mediated by prostaglandins | Q41719835 | ||
| Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages | Q41729387 | ||
| Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones | Q41784037 | ||
| Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor | Q41839655 | ||
| Neurophysiological and endocrine consequences of immune activity | Q42493131 | ||
| Role of bradykinin in the vascular permeability response induced by carrageenin in rats | Q42705615 | ||
| Immunosuppressive activity of corticotrophin-releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells | Q42792633 | ||
| Immuno-Reactive and Bioactive Corticotropin-Releasing Factor in Rat Thymus | Q43445118 | ||
| Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor | Q43956860 | ||
| Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus | Q44514036 | ||
| Neuroendocrine-immune system interactions The immune-hypothalamo-pituitary-adrenal axis | Q44795984 | ||
| Central corticotropin-releasing factor suppresses natural killer cytotoxicity. | Q46009403 | ||
| Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production. | Q46032321 | ||
| The adrenocorticotropin response to interleukin-1 beta instilled into the rat median eminence depends on the local release of catecholamines | Q46110809 | ||
| CRF activates autonomic nervous system and reduces natural killer cytotoxicity | Q46258975 | ||
| Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor | Q46409186 | ||
| Corticosterone: narrow range required for normal body and thymus weight and ACTH. | Q47219040 | ||
| Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides | Q48120891 | ||
| The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation | Q48478355 | ||
| Capsaicin depletes corticotropin-releasing factor-like immunoreactive neurons in the rat spinal cord and medulla oblongata | Q48664624 | ||
| Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord | Q48737369 | ||
| Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity | Q48961758 | ||
| ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. | Q48970812 | ||
| Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. | Q49068345 | ||
| Neuroendocrine-immune interactions. | Q51139562 | ||
| Somatostatin may participate in the antiinflammatory actions of glucocorticoids. | Q52206523 | ||
| Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. | Q52207285 | ||
| Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. | Q52235332 | ||
| Central corticotropin releasing factor reduces natural cytotoxicity Time course of action | Q57174892 | ||
| Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need | Q59059897 | ||
| Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures | Q59070003 | ||
| Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins | Q59081573 | ||
| Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes | Q61054361 | ||
| Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells | Q61855133 | ||
| Influence of CRF and α-MSH on the migration of human monocytes in vitro | Q62852115 | ||
| Modulation of natural killer cell-mediated lysis by corticotropin-releasing neurohormone | Q67947911 | ||
| Stimulation of interleukin-6 production by corticotropin-releasing factor | Q68193654 | ||
| Activation of Thymocyte Deoxyribonucleic Acid Degradation by Endogenous Glucocorticoids | Q68239574 | ||
| Receptor-mediated immunomodulation by corticotropin-releasing factor | Q68295560 | ||
| In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release | Q69376304 | ||
| Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression | Q69742012 | ||
| Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin | Q69824356 | ||
| Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease | Q69829052 | ||
| Human recombinant interleukin-1 beta and -alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 and cAMP independent manner | Q69848401 | ||
| Interleukin-1 regulates corticosterone secretion from the rat adrenal gland through a catecholamine-dependent and prostaglandin E2-independent mechanism | Q72019825 | ||
| Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus | Q72204183 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 131-136 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | CRH and the immune system | |
| P478 | volume | 72 |
| Q33963801 | A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblasts |
| Q37369171 | Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes |
| Q47131337 | Altered Neuroendocrine Immune Responses, a Two-Sword Weapon against Traumatic Inflammation |
| Q44173271 | Androstenediol (AED) prevents neuroendocrine-mediated suppression of the immune response to an influenza viral infection |
| Q36600274 | Behavioral effects of peripheral corticotropin-releasing factor during maternal separation may be mediated by proinflammatory activity |
| Q47887043 | Beta-endorphin in the immune system--mediator of pain and stress? |
| Q47815993 | Bipolar-shape response of human neutrophils to corticotropin-releasing factor. |
| Q91637679 | Brain and Pituitary Response to Vaccination in Gilthead Seabream (Sparus aurata L.). |
| Q35057714 | BuShenYiQi granule inhibits atopic dermatitis via improving central and skin Hypothalamic-Pituitary-Adrenal axis function |
| Q34241410 | CRH in chronic inflammatory stress |
| Q35637260 | Characterization of a novel chicken muscle disorder through differential gene expression and pathway analysis using RNA-sequencing |
| Q35148867 | Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems |
| Q28236185 | Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes |
| Q73271613 | Corticotropin releasing factor induces proliferation of cerebellar astrocytes |
| Q51901426 | Corticotropin-Releasing Factor Regulates TLR4 Expression in the Colon and Protects Mice From Colitis |
| Q28590843 | Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation |
| Q36755440 | Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. |
| Q73922670 | Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide |
| Q36393230 | Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine |
| Q39533855 | Cutaneous induction of corticotropin releasing hormone by Propionibacterium acnes extracts |
| Q33751836 | Deducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian models |
| Q36970597 | Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system |
| Q47743864 | Does IL-6 release ACTH by exerting a direct effect in the rat anterior pituitary |
| Q37537023 | Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. |
| Q90589213 | Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders |
| Q91623234 | Fish pituitary show an active immune response after in vitro stimulation with Vibrio bacterin |
| Q26774258 | Genitourinary mast cells and survival |
| Q48331132 | Glucocorticoids down-regulate lipopolysaccharide-induced de novo production of neurotensin mRNA in the rat hypothalamic, paraventricular, corticotrophin-releasing hormone neurons |
| Q30450552 | Hypothalamic neurohormones and immune responses |
| Q24531350 | Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection |
| Q55363956 | In-Home Sleep Recordings in Military Veterans With Posttraumatic Stress Disorder Reveal Less REM and Deep Sleep <1 Hz. |
| Q46365861 | Induction of experimental allergic encephalomyelitis in a low-susceptible Albino Oxford rat strain by somatostatin analogue SMS 201-995. |
| Q37002385 | Inflammation and neuropeptides: the connection in diabetic wound healing |
| Q73953339 | Inflammatory response to cold injury in remote organs is reduced by corticotropin-releasing factor |
| Q38915614 | Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis |
| Q35204601 | Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation |
| Q99416979 | Investigation of predictors of interest in a brief mindfulness-based intervention and its effects in patients with psoriasis at a rehabilitation clinic (SkinMind): an observational study and randomised controlled trial |
| Q34363640 | Key role of CRF in the skin stress response system |
| Q38635491 | Lack of CRH Affects the Behavior but Does Not Affect the Formation of Short-Term Memory |
| Q83029950 | Mast cells and inflammation |
| Q36328491 | Maternal inhibition of infant behavioral response following isolation in novel surroundings and inflammatory challenge |
| Q44583800 | Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart |
| Q44514301 | Modulation of type I IL-1 receptor and IL-1 beta mRNA expression followed by endotoxin treatment in the corticotropin-releasing hormone-deficient mouse. |
| Q73258433 | Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo |
| Q48232088 | Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis |
| Q48427552 | Neuroendocrine and immune system interactions in stress and depression |
| Q39091869 | Neuroendocrinology of mast cells: Challenges and controversies |
| Q35758842 | Neuroimmune endocrine effects of antidepressants |
| Q36618726 | Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells |
| Q36371956 | Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis |
| Q35032928 | Neuropeptides: modulators of immune responses in health and disease |
| Q34479187 | Neurotensin and CRH interactions augment human mast cell activation |
| Q32066343 | New agents for the medical treatment of interstitial cystitis |
| Q48339108 | Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CR |
| Q36515510 | Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions |
| Q96134668 | Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances |
| Q34285045 | Perinatal stress, brain inflammation and risk of autism-review and proposal |
| Q44767414 | Plasma cortisol concentration increases within 6 hours of stabling in RAO-affected horses |
| Q34582310 | Present concepts on the inflammatory modulators with special reference to cytokines |
| Q35028500 | Proinflammatory activity and the sensitization of depressive-like behavior during maternal separation |
| Q44012909 | Prostaglandins mediate lipopolysaccharide effects upon cholecystokinin and neurotensin phenotypes in neuroendocrine corticotropin-releasing hormone neurons: in situ hybridization evidence in the rat. |
| Q42177177 | Regulation and roles of urocortins in the vascular system |
| Q36674871 | Regulation of appetite and insulin signaling in inflammatory states |
| Q36753635 | Role of neuropeptides in inflammatory bowel disease |
| Q34457026 | Series introduction. The immuno-neuroendocrine interface |
| Q44294030 | Sexually dimorphic stress and pro-inflammatory cytokine responses to an intravenous corticotropin-releasing hormone challenge of Brahman cattle following transportation |
| Q33711432 | Shared resources between the neural and immune systems: semaphorins join the ranks |
| Q34173427 | Signal transduction in the hypothalamic corticotropin-releasing factor system and its clinical implications |
| Q33668425 | Stress-induced mast cell activation in glabrous and hairy skin |
| Q74545188 | Stress-induced sickness behaviors: an alternative hypothesis for responses during maternal separation |
| Q34520745 | The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation |
| Q34178687 | The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review |
| Q28572893 | Urocortin-Related Peptides Increase Interleukin-6 Output via Cyclic Adenosine 5′-Monophosphate-Dependent Pathways in A7r5 Aortic Smooth Muscle Cells |
| Q46384578 | Vasopressin-containing neurons of the hypothalamic parvocellular paraventricular nucleus of the jerboa: plasticity related to immobilization stress |
Search more.